Search

Anmol Gulati

from Watertown, MA
Get Report
Also known as:
Bhakti Varma
Related to:
Anika Gulati, 31Neesha K Gulati, 35
Connected to:
Ajay Gulati, 55Amneet Gulati, 38Archana Gulati, 52Ashok K Gulati, 73Avnish Gulati, 57Damaris Gulati, 59Deepti Gulati, 62Dhiraj Gulati, 43Disha Gulati, 44Gaurav K Gulati, 38

Anmol Gulati Phones & Addresses

  • Watertown, MA
  • Champaign, IL
  • Cambridge, MA

Work

Company: Merck Dec 2016 Position: Research scientist

Education

Degree: Masters School / High School: Massachusetts Institute of Technology 2014 to 2016 Specialities: Chemistry

Skills

Research • Data Analysis • Microsoft Office • Matlab • Chemistry • Microsoft Excel • Organic Chemistry • Powerpoint • Public Speaking • Teaching • Leadership • Teamwork • Spectroscopy • C • Microsoft Word • C++ • Science • High Performance Liquid Chromatography • Nuclear Magnetic Resonance • Characterization • Purification • Laboratory Skills • Cell Biology • Synthetic Organic Chemistry • Statistics • Customer Service • Higher Education • Biochemistry • Molecular Biology • Uv/Vis Spectroscopy • Drug Delivery • Life Sciences • Organic Synthesis • Mass Spectrometry • Analytical Chemistry • Chromatography

Languages

Hindi • English • French • Punjabi • Marathi

Industries

Chemicals

Resumes

Resumes

Anmol Gulati Photo 1

Research Scientist

View page
Location:
206 east Peabody Dr, Champaign, IL 61820
Industry:
Chemicals
Work:
Merck
Research Scientist
Massachusetts Institute of Technology (Mit) Aug 2014 - Oct 2016
Graduate Research Assistant, Doctor Elizabeth Nolan
Massachusetts Institute of Technology (Mit) Aug 2014 - May 2015
Graduate Teaching Assistant
University of Illinois at Urbana-Champaign Aug 2013 - May 2014
Teaching Assistant
University of Illinois at Urbana-Champaign Aug 2012 - May 2014
Research Assistant: Dr Eric Oldfield
Education:
Massachusetts Institute of Technology 2014 - 2016
Masters, Chemistry University of Illinois at Urbana - Champaign 2010 - 2014
Bachelors, Bachelor of Science, Chemistry, Organic Chemistry Delhi Public School, R.k. Puram 2010
Delhi Public School Noida
Skills:
Research
Data Analysis
Microsoft Office
Matlab
Chemistry
Microsoft Excel
Organic Chemistry
Powerpoint
Public Speaking
Teaching
Leadership
Teamwork
Spectroscopy
C
Microsoft Word
C++
Science
High Performance Liquid Chromatography
Nuclear Magnetic Resonance
Characterization
Purification
Laboratory Skills
Cell Biology
Synthetic Organic Chemistry
Statistics
Customer Service
Higher Education
Biochemistry
Molecular Biology
Uv/Vis Spectroscopy
Drug Delivery
Life Sciences
Organic Synthesis
Mass Spectrometry
Analytical Chemistry
Chromatography
Languages:
Hindi
English
French
Punjabi
Marathi

Publications

Us Patents

N-(Heteroaryl) Quinazolin-2-Amine Derivatives As Lrrk2 Inhibitors, Pharmaceutical Compositions, And Uses Thereof

View page
US Patent:
20230023066, Jan 26, 2023
Filed:
Oct 20, 2020
Appl. No.:
17/769814
Inventors:
Mitchell H. KEYLOR - Boston MA, US
Michael j. ARDOLINO - Boston MA, US
Ryan W. CHAU - Boston MA, US
Peter H. FULLER - Boston MA, US
Anmol GULATI - Boston MA, US
Rebecca Elizabeth JOHNSON - Boston MA, US
Solomon D. KATTAR - Boston MA, US
Kaila A. MARGREY - Boston MA, US
Santhosh F. NEELAMKAVIL - Edison NJ, US
Xin YAN - Boston MA, US
Elsie C. YU - Boston MA, US
Cayetena Carmela ZARATE SAEZ - Boston MA, US
- Rahway NJ, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
C07D 403/14
C07D 405/14
C07D 403/12
C07D 417/14
C07D 401/14
C07D 413/14
C07D 409/14
Abstract:
The present invention is directed to substituted certain N-(heteroaryl)quinazolin-2-amine derivatives of Formula (I): and pharmaceutically acceptable salts thereof, wherein J, R, and R, are as defined herein, which are potent inhibitors of LRRK2 kinase and may be useful in the treatment or prevention of diseases in which the LRRK2 kinase is involved, such as Parkinson's Disease and other diseases and disorders described herein. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of diseases, such as Parkinson's disease, in which LRRK-2 kinase is involved.
Control profile
Anmol Gulati from Watertown, MA Get Report